Chung Hsing announced on June 22, 2026, that it acquired 140,000 shares of United Biomedical common stock, with a total transaction value of approximately NT$331 million, increasing its ownership stake to 0.25%, as part of its investment portfolio strategy.
AI Analysis
Frequently Asked Questions
Q: What kind of company is Chung Hsing?
A: A Taiwanese electronics components manufacturer focusing on semiconductor materials and financial investments.
Q: What is Chung Hsing's ownership ratio in United Biomedical?
A: Holds 235,000 shares, representing a 0.25% stake.
Q: Who approved this transaction?
A: Approved directly by the Chairman, not by the board of directors.